SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

2.

Oleanolic acid from grapes may increase chemotherapy effectiveness

3.

Mortality up for children with leukemia from lowest SES neighborhoods

4.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

5.

Booze and Pancreatic Cancer Risk; From 'Hospice' to 'Hope'; Gen Z-ers Skip Screening


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot